[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339926-105":59,"doc-detail-339926-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tnm-stage-in-the-nordic-cancer-registries-2004-2016-registration-and-availability","TNM stage in the Nordic Cancer Registries 2004-2016 - Registration and availability","","Cancer stage at diagnosis is a key predictor of survival, and TNM stage (T, N, and M) supports cancer diagnosis, management, control, and surveillance. This study provides an overview of TNM availability and trends in stage distribution across Nordic countries from 2004–2016, using a validated algorithm for assigning stages. It also assesses stage recording quality via TNM stage-specific 1-year relative survival for selected cancer sites.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tnm-stage-in-the-nordic-cancer-registries-2004-2016-registration-and-availability/339926/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tnm-stage-in-the-nordic-cancer-registries-2004-2016-registration-and-availability/339926.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on TNM staging in the Nordic registries?","Question",{"text":112,"@type":113},"The study examines how TNM information is acquired in Nordic cancer registries and compares the availability, comparability, and distribution of TNM stage between registries from 2004–2016.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TNM information obtained and analyzed in the study?",{"text":117,"@type":113},"TNM information was collected from cancer registries in Denmark, Norway, Sweden, and Iceland for multiple cancer sites. Availability and comparability were studied across three periods (2004–2008, 2009–2013, 2014–2016) using a validated algorithm for stage assignment.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about TNM stage availability and survival differences?",{"text":121,"@type":113},"Denmark, Sweden, and Iceland showed available TNM stage proportions of about 75–95%, while Norway had lower proportions. One-year relative survival differed more between TNM stages than between countries, supporting TNM stage as an important survival predictor and indicating similar stage recording across Nordic countries.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339926,1790710422,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ORIGINAL REPORT  \nTNM stage in the Nordic Cancer Registries 2004–2016: Registration and availability  \nGerda Engholma, Frida E. Lundbergb,c, Simon M. Kønigd, Elínborg Ólafsdóttire, Tom B. Johannesenf, David Petterssong, Nea Malilah, Lina S. Mørchi, Anna L. V. Johanssonb,f and Søren Friisd  \na Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark; bDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; c Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; dDanish Cancer Institute, Cancer Epidemiology and Surveillance, Danish Cancer Society, Copenhagen, Denmark; e Icelandic Cancer Registry, Reykjavik, Iceland; fCancer Registry of Norway, Oslo, Norway; gSwedish Cancer Registry, National Board of Health and Welfare, Stockholm, Sweden; hFinnish Cancer Registry, Helsinki, Finland; iDanish Cancer Institute, Cancer and Medicine, Danish Cancer Society, Copenhagen, Denmark  \nABSTRACT  \nBackground and purpose: Stage at cancer diagnosis is an important predictor of cancer survival. TNM stage is constructed for anatomic solid cancer diagnoses from tumor size (T), nodal spread (N) and distant metastasis (M) and categorized in groups 0–I, II, II and IV. TNM stage is imperative in cancer diagnosis, management and control, and of high value in cancer surveillance, for example, monitoring of stage distributions. This study yields an overview ofTNM availability and trends in stage distribution in the Nordic countries for future use in monitoring and epidemiologic studies.  \nMaterial and methods: TNM information was acquired from the cancer registries in Denmark, Norway, Sweden, and Iceland during 2004–2016 for 26 cancer sites in the three former countries and four in Iceland. We studied availability, comparability, and distribution ofTNM stage in three periods: 2004–2008, 2009– 2013, and 2014–2016, applying a previously validated algorithm of‘N0M0 for NXMX’. For cancers of colon, rectum, lung, breast, and kidney, we examined TNM stage-specific 1-year relative survival to evaluate the quality in registration ofTNM between countries.  \nResults: Denmark, Sweden, and Iceland exhibited available TNM stage proportions of 75–95% while proportions were lower in Norway. Proportions increased in Sweden over time but decreased in Denmark. One-year relative survival differed substantially more between TNM stages than between countries emphasizing that TNM stage is an important predictor for survival and that stage recording is performed similarly in the Nordic countries.  \nInterpretation: Assessment and registration ofTNM stage is an imperative tool in evaluations of trends in cancer survival between the Nordic countries.  \nARTICLE HISTORY  \nReceived December 10 2023  \nAccepted April 5 2024 Published 7 May 2024  \nKEYWORDS  \nCancer stage; TNM; Cancer registries; NORDCAN; relative survival  \nBackground  \nStage at cancer diagnosis is an important predictor of cancer survival [1, 2] . For solid tumors, stage of disease is mainly classified according to the Tumor-Nodal-Metastasis (TNM) classification system. The individual components, that is, T (tumor size), N (nodal spread), and M (metastasis), follow strict definitions, and the precise TNM stage is constructed from all three components and categorized in stages 0, I, II, II and IV [2] . Information onTNM stage is an imperative tool in cancer diagnosis and management [1, 2]. Moreover, the TNM stage is of high value in cancer control, surveillance, and research, for example, monitoring of trends in stage distribution at cancer diagnosis and monitoring and benchmarking of cancer incidence and survival [2, 3] .  \nThe nationwide cancer registries in the Nordic countries provide data for collaborative and comparative studies on cancer incidence and survival [4] . To facilitate access to Nordic cancer statistics, a publicly available database, NORDCAN, has  \nbeen developed providing aggregate statistics on cancer incidence, cancer mortali","cbCaihDsIrwrS6mt","https://ap.wps.com/l/cbCaihDsIrwrS6mt","pdf",2762453,"English","# Background and purpose\n# Material and methods\n# Results\n# Interpretation\n# Background\n## Nordic cancer registries and TNM registration\n## Rationale for comparing TNM stages\n# Key terms and data sources\n# Article information","[{\"question\":\"What is the main focus of this study on TNM staging in the Nordic registries?\",\"answer\":\"The study examines how TNM information is acquired in Nordic cancer registries and compares the availability, comparability, and distribution of TNM stage between registries from 2004–2016.\"},{\"question\":\"How was TNM information obtained and analyzed in the study?\",\"answer\":\"TNM information was collected from cancer registries in Denmark, Norway, Sweden, and Iceland for multiple cancer sites. Availability and comparability were studied across three periods (2004–2008, 2009–2013, 2014–2016) using a validated algorithm for stage assignment.\"},{\"question\":\"What did the results show about TNM stage availability and survival differences?\",\"answer\":\"Denmark, Sweden, and Iceland showed available TNM stage proportions of about 75–95%, while Norway had lower proportions. One-year relative survival differed more between TNM stages than between countries, supporting TNM stage as an important survival predictor and indicating similar stage recording across Nordic countries.\"}]","TNM stage in the Nordic Cancer Registries 2004-2016 - Registration and availability | PDF",1790033135,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9efcd439e9ac62053a717ae9f807434.webp",983,1280,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e80d4909a6e26c98eab6e4b2e182da92.webp",982,1278,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43711aca8f5fa0e90df18d381054bdef.webp",981,1277,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb785942ed7ad88ff80473198ba2e599.webp",980,1276]